USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: GENOMICS USA, INC.
City: TUCSON
State: AZ
Zip+4: 85710-
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,214,232.00 3
SBIR Phase II $7,044,446.00 3

Award List:

Population-scale HLA typing for home land defense

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: HHS
Principal Investigator: Rahul Mitra
Award Amount: $498,784.00
Abstract:
DESCRIPTION (provided by applicant): Genomics USA, Inc. (GUSA) is a biotech start-up focused on microarray technology development. GUSA has previously developed a combination of genomics IT and microarray technology to enable the mass production of medium-density DNA microarrays at very low cost.… More

HLA Chip Product for FDA 510K Approval

Award Year / Program / Phase: 2006 / SBIR / Phase II
Agency: HHS
Principal Investigator: Krishna Jayaraman
Award Amount: $2,798,132.00
Abstract:
DESCRIPTION (provided by applicant): Current technology for HLA typing does not have rapid field response capability because it too expensive and is too complicated to be implemented in the context of a population-scale emergency. The ultimate goal of this proposal is to develop a simple, accurate,… More

A Low Cost Microarray for Population-Scale AIDS Risk Analysis: The AIDS Chip

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Michael E. Hogan
Award Amount: $599,686.00
Abstract:
DESCRIPTION (provided by applicant): There is rapidly growing HIV literature, which has discovered a set of inherited genetic differences which can predict: a) the fraction of an infected population who will progress slowly, or never progress to AIDS sympt oms (the so-called Elite Controllers), or… More

HLA Chip Product for FDA 510K Approval

Award Year / Program / Phase: 2009 / SBIR / Phase II
Agency: HHS
Principal Investigator: Krishna Jayaraman
Award Amount: $2,513,348.00
Abstract:
DESCRIPTION (provided by applicant): We describe here a Phase II Competitive Renewal grant application, which will support a three year program of ASHI (American Society of Histocompatibility and Immunology) and FDA 510K review, for the HLA-Chip which we have developed over the past two years,… More

The Transfusion Chip: A Simple, Low Cost Microarray for DNA Based Blood Typing

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Michael E. Hogan – 847-359-1032
Award Amount: $115,762.00
Abstract:
DESCRIPTION (provided by applicant): Low-cost nucleic acid analysis, to detect HIV and HBV, has revolutionized screening of the blood supply. In spite of that new genetic sophistication, traditional blood group typing [ABO, Rh] is still performed, for themost part, via variations upon 80-year-old… More

The Transfusion Chip: Phase II Technology Validation

Award Year / Program / Phase: 2013 / SBIR / Phase II
Agency: HHS
Principal Investigator: Michael E. Hogan – 520-904-1715
Award Amount: $1,732,966.00
Abstract:
DESCRIPTION (provided by applicant): Blood-Typing is the progenitor of the entire field of personalized medicine. In the recently awarded 6-month Phase I, we proposed to take the first step in the development of an extremely-low-cost microarray test, TheTransfusion-Chip (T-Chip) which convert the… More